The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations - PubMed (original) (raw)
The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations
Chan Kwon Jung et al. J Clin Endocrinol Metab. 2014 Feb.
Abstract
Context: Thyroid cancer incidence rates in the United States and globally have increased steadily over the last 40 years, primarily due to a tripling of the incidence of papillary thyroid carcinoma (PTC).
Objective: The purpose of this study was to analyze trends in demographic, clinical, pathologic, and molecular characteristics of PTC from 1974 to 2009.
Design and setting: We identified and histologically reviewed 469 consecutive cases of PTC from one US institution from 4 preselected periods (1974 to 1985, 1990 to 1992, 2000, and 2009) and assessed BRAF and RAS point mutations and RET/PTC rearrangements among 341 tumors ≥0.3 cm in size. Changes over time were analyzed using polytomous and binary logistic regression; all analyses were adjusted for age and sex.
Results: During this period, the median age of patients at diagnosis increased from 37 to 53 years (P < .001) and the percentage of microcarcinomas (≤1.0 cm) increased from 33% to 51% (P < .001), whereas extrathyroidal extension and advanced tumor stage decreased from 40% to 21% (P = .005) and from 43% to 28% (P = .036), respectively. Changes in tumor histopathology showed a decrease in classic PTC and an increase in the follicular variant (P < .001). The proportion of tumors with a BRAF mutation was stable (∼46%) but increased from 50% to 77% (P = .008) within classic papillary PTCs. The proportion of tumors with RAS mutations increased from 3% to 25% and within follicular pattern tumors from 18% to 44% (P < .001). The proportion of RET/PTC rearrangements decreased from 11% to 2% (P = .038).
Conclusions: Similar to US national trends, we found an increasing age at diagnosis and greater detection of smaller-sized intrathyroidal PTCs. However, the overall proportion of BRAF mutations remained stable. Sharply rising percentages of the follicular variant histology and RAS mutations after 2000 suggest new and more recent etiologic factors. The increased incidence is not likely to be due to environmental or therapeutic radiation because the percentage of RET/PTC rearrangements decreased.
Figures
Figure 1.
Time trends in the age- and sex-adjusted prevalence (with 95% CI) of specific histopathologic types of PTC. A, Time trends for the most common types of PTC: classic papillary, follicular variant, and microcarcinoma defined as tumor ≤1 cm in size. B, Time trends for classic papillary and follicular variant of PTC irrespective of tumor size, ie, with microcarcinomas reclassified based on their growth pattern. C, Time trends for encapsulated and infiltrative types of the follicular variant of PTC (University of Pittsburgh Medical Center, 1974–2009).
Figure 2.
Time trends in the age- and sex-adjusted prevalence (with 95% CI) of the three mutation types in papillary thyroid carcinoma (University of Pittsburgh Medical Center, 1974–2009).
Comment in
- Molecular profiles of papillary thyroid tumors have been changing in the last decades: how could we explain it?
Elisei R. Elisei R. J Clin Endocrinol Metab. 2014 Feb;99(2):412-4. doi: 10.1210/jc.2014-1130. J Clin Endocrinol Metab. 2014. PMID: 24502514 Free PMC article. No abstract available. - [Surgical relevance of new biomarkers in papillary carcinoma of the thyroid].
Dralle H. Dralle H. Chirurg. 2014 May;85(5):447. doi: 10.1007/s00104-014-2747-5. Chirurg. 2014. PMID: 24696317 German. No abstract available.
Similar articles
- Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.
Kowalska A, Walczyk A, Kowalik A, Pałyga I, Trybek T, Kopczyński J, Kajor M, Chrapek M, Pięciak L, Chłopek M, Góźdź S, Kamiński G. Kowalska A, et al. Thyroid. 2016 Apr;26(4):543-51. doi: 10.1089/thy.2015.0352. Epub 2016 Feb 18. Thyroid. 2016. PMID: 26889698 - Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
Mostoufi-Moab S, Labourier E, Sullivan L, LiVolsi V, Li Y, Xiao R, Beaudenon-Huibregtse S, Kazahaya K, Adzick NS, Baloch Z, Bauer AJ. Mostoufi-Moab S, et al. Thyroid. 2018 Jan;28(1):60-67. doi: 10.1089/thy.2017.0059. Epub 2017 Dec 11. Thyroid. 2018. PMID: 29108474 Free PMC article. - Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
Musholt PB, Musholt TJ, Morgenstern SC, Worm K, Sheu SY, Schmid KW. Musholt PB, et al. World J Surg. 2008 May;32(5):722-8. doi: 10.1007/s00268-007-9431-6. World J Surg. 2008. PMID: 18235983 - The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review.
Vuong HG, Altibi AM, Abdelhamid AH, Ngoc PU, Quan VD, Tantawi MY, Elfil M, Vu TL, Elgebaly A, Oishi N, Nakazawa T, Hirayama K, Katoh R, Huy NT, Kondo T. Vuong HG, et al. Oncotarget. 2017 Feb 7;8(6):10637-10649. doi: 10.18632/oncotarget.12885. Oncotarget. 2017. PMID: 27793009 Free PMC article. Review. - Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Quiros RM, et al. Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073. Cancer. 2005. PMID: 15880523 Review.
Cited by
- Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances and other persistent organic pollutants.
Cirello V, Lugaresi M, Moneta C, Dufour P, Manzo A, Carbone E, Colombo C, Fugazzola L, Charlier C, Pirard C. Cirello V, et al. Eur Thyroid J. 2024 May 20;13(3):e230192. doi: 10.1530/ETJ-23-0192. Print 2024 Jun 1. Eur Thyroid J. 2024. PMID: 38657654 Free PMC article. - Novel role of lncRNAs regulatory network in papillary thyroid cancer.
Su Y, Mei L, Jiang T, Wang Z, Ji Y. Su Y, et al. Biochem Biophys Rep. 2024 Feb 29;38:101674. doi: 10.1016/j.bbrep.2024.101674. eCollection 2024 Jul. Biochem Biophys Rep. 2024. PMID: 38440062 Free PMC article. Review. - MicroRNA Expression Profiling-Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes.
Silaghi H, Pop LA, Georgescu CE, Muntean D, Crișan D, Silaghi P, Lungu I, Nasui BA, Dulf EH, Braicu C, Berindan-Neagoe I, Silaghi CA. Silaghi H, et al. Biomedicines. 2024 Jan 9;12(1):136. doi: 10.3390/biomedicines12010136. Biomedicines. 2024. PMID: 38255241 Free PMC article. - Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes.
Wang X, Yu Y, Ji Y, Ma Z, Tan J, Jia Q, Li N, Zheng W. Wang X, et al. BMC Cancer. 2023 Nov 8;23(1):1077. doi: 10.1186/s12885-023-11591-x. BMC Cancer. 2023. PMID: 37940857 Free PMC article. - Developing Models to Predict _BRAF_V600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression.
Harahap AS, Subekti I, Panigoro SS, Asmarinah, Lisnawati, Werdhani RA, Agustina H, Khoirunnisa D, Mutmainnah M, Gultom FL, Assadyk AH, Ham MF. Harahap AS, et al. Biomedicines. 2023 Oct 16;11(10):2803. doi: 10.3390/biomedicines11102803. Biomedicines. 2023. PMID: 37893176 Free PMC article.
References
- Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer. 2009;115:3801–3807 - PubMed
- Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–2167 - PubMed
- Albores-Saavedra J, Henson DE, Glazer E, Schwartz AM. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype—papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol. 2007;18:1–7 - PubMed
- Colonna M, Guizard AV, Schvartz C, et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur J Cancer. 2007;43:891–900 - PubMed
- Burgess JR, Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid. 2006;16:47–53 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials